These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35466806)

  • 1. Appearance and Performance Enhancing Drugs and Substances: The Role of the School Nurse.
    Siegmund LA
    NASN Sch Nurse; 2022 Sep; 37(5):263-269. PubMed ID: 35466806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success, Failure, and Unfinished Business of Education, Prevention, Policy, and Intervention Programs on Substance Misuse in Brazilian Sport.
    Santos AM
    Subst Use Misuse; 2015; 50(8-9):1139-43. PubMed ID: 26361918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional supplements and ergogenic AIDS.
    Liddle DG; Connor DJ
    Prim Care; 2013 Jun; 40(2):487-505. PubMed ID: 23668655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Testing US Student-Athletes for Performance-Enhancing Substance Misuse: A Flawed Process.
    Bahrke MS
    Subst Use Misuse; 2015; 50(8-9):1144-7. PubMed ID: 26361919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position stand on androgen and human growth hormone use.
    Hoffman JR; Kraemer WJ; Bhasin S; Storer T; Ratamess NA; Haff GG; Willoughby DS; Rogol AD
    J Strength Cond Res; 2009 Aug; 23(5 Suppl):S1-S59. PubMed ID: 19620932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sports psychiatrist and performance-enhancing drugs.
    Creado S; Reardon C
    Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anabolic androgenic steroids and polypharmacy: a review of the literature.
    Dodge T; Hoagland MF
    Drug Alcohol Depend; 2011 Apr; 114(2-3):100-9. PubMed ID: 21232881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Faster, higher, stronger: knowledge about old and new doping substances].
    Pieters T; de Hon O
    Ned Tijdschr Geneeskd; 2013; 157(28):A6450. PubMed ID: 23841931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doping among adolescent athletes.
    Yesalis CE; Bahrke MS
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):25-35. PubMed ID: 10932808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.
    Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance-enhancing drugs: understanding the risks.
    Hatton CK; Green GA; Ambrose PJ
    Phys Med Rehabil Clin N Am; 2014 Nov; 25(4):897-913. PubMed ID: 25442165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of anabolic-androgenic steroids by Canadian students.
    Melia P; Pipe A; Greenberg L
    Clin J Sport Med; 1996 Jan; 6(1):9-14. PubMed ID: 8925377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():30-43. PubMed ID: 26881771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances.
    Cadwallader AB; Murray B
    Int J Sport Nutr Exerc Metab; 2015 Aug; 25(4):396-404. PubMed ID: 25675030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for performance enhancing substances and quantification of ethanol in different Arishta manufactured in Sri Lanka.
    Fernando N; Pigera S; Rashani N; Fernando R; Weerasinghe P; Godakumbura D; Niriella M; Jayawickreme S; De Silva A
    Ceylon Med J; 2020 Dec; 65(4):112-117. PubMed ID: 34825559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.